Overview
No overview information available.
Background
No background information available.
Indication
中枢抑制药。加强大脑皮层的抑制过程,具有镇静作用,用于神经衰弱及癫痫等。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
Calcium Bromide Injection | 国药准字H32024622 | 化学药品 | 注射剂 | 7/30/2020 | |
Calcium Bromide Injection | 国药准字H61022424 | 化学药品 | 注射剂 | 10/13/2023 | |
Calcium Bromide Injection | 国药准字H23022464 | 化学药品 | 注射剂 | 3/6/2023 | |
Calcium Bromide Injection | 国药准字H43021522 | 化学药品 | 注射剂 | 6/22/2020 | |
Calcium Bromide Injection | 国药准字H41023955 | 化学药品 | 注射剂 | 8/14/2020 | |
Calcium Bromide Injection | 国药准字H32024623 | 化学药品 | 注射剂 | 7/30/2020 | |
Calcium Bromide Injection | 国药准字H41023956 | 化学药品 | 注射剂 | 8/14/2020 | |
Calcium Bromide Injection | 国药准字H23021036 | 化学药品 | 注射剂 | 3/6/2023 | |
Calcium Bromide Injection | 国药准字H23022465 | 化学药品 | 注射剂 | 3/6/2023 | |
Calcium Bromide Injection | 国药准字H23021037 | 化学药品 | 注射剂 | 3/6/2023 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |